MedTrace Logo

Systemic Lupus Erythematosus and Accelerated Aging

NCT05698173 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-09-04

No results posted yet for this study

Summary

The study aims at evaluating the phenomena of immune system aging in patients with Systemic lupus erythematosus.

Conditions

Interventions

BIOLOGICAL

blood sample

48 ml whole blood for Peripheral blood mononuclear cell (PBMC) and serum isolation

BIOLOGICAL

blood sample

blood for Peripheral blood mononuclear cell (PBMC) and serum isolation

Sponsors & Collaborators

  • University of Bordeaux

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Noemie GENSOUS, MD · University Hospital, Bordeaux

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-08
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05698173 on ClinicalTrials.gov